Skip navigation
MedlinePlus Trusted Health Information for You U.S. National Library of MedicineNational Institutes of Health
Contact Us FAQs Site Map About MedlinePlus
español Home Health Topics Drugs & Supplements Medical Encyclopedia Dictionary News Directories Other Resources

 

Medical Encyclopedia

Other encyclopedia topics:  A-Ag  Ah-Ap  Aq-Az  B-Bk  Bl-Bz  C-Cg  Ch-Co  Cp-Cz  D-Di  Dj-Dz  E-Ep  Eq-Ez  F  G  H-Hf  Hg-Hz  I-In  Io-Iz  J  K  L-Ln  Lo-Lz  M-Mf  Mg-Mz  N  O  P-Pl  Pm-Pz  Q  R  S-Sh  Si-Sp  Sq-Sz  T-Tn  To-Tz  U  V  W  X  Y  Z  0-9 

Central pontine myelinolysis

Printer-friendly versionEmail this page to a friend
Contents of this page:

Illustrations

Central nervous system
Central nervous system

Alternative Names    Return to top

CPM

Definition    Return to top

Central pontine myelinolysis is nerve damage caused by the destruction of the layer (myelin sheath) covering nerve cells in the brainstem (pons).

Causes    Return to top

The destruction of the myelin sheath that coats nerve cells prevents signals from being properly conducted within the nerve. This decreases its ability to communicate with other cells. The most common cause of central pontine myelinolysis is a rapid, drastic change in sodium levels in the body. Most commonly, this occurs when someone is being treated for low levels of sodium (hyponatremia) and the levels rise too fast. It also can occasionally occur when high levels of sodium in the body (hypernatremia) are corrected too quickly.

This condition does not occur on its own. It is a complication of treatment for other conditions or the other conditions themselves.

People at risk include those with low sodium levels from any cause, alcoholism, Wernicke-Korsakoff syndrome, general ill health, and malnutrition associated with serious illnesses.

Symptoms    Return to top

Additional symptoms that may be associated with this disease:

Exams and Tests    Return to top

An examination may indicate involvement of all four arms and legs (spastic quadriplegia) or weakness of the face, arms, and legs (upper motor neuron syndromes). Reflexes may be abnormal. An eye examination may show loss of control of eye muscles, particularly cranial nerve VI paralysis (see cranial mononeuropathy VI).

A head MRI scan would reveal an abnormality in the brainstem (pons). This is the main diagnostic test.

Other tests may include:

Treatment    Return to top

This is an emergency disorder that requires hospitalization for diagnosis and treatment. There is no known cure for central pontine myelinolysis and treatment is focused on relieving symptoms.

Double vision may be reduced with the use of an eye patch.

Physical therapy may help maintain muscle strength, mobility and function in weakened arms and legs.

Outlook (Prognosis)    Return to top

The nerve damage caused by central pontine myelinolysis is usually long-lasting. The disorder can cause serious chronic (long-term) disability.

Possible Complications    Return to top

When to Contact a Medical Professional    Return to top

Go to the emergency room or call 911 if seizures, muscle weakness, or other symptoms of this condition occur.

Prevention    Return to top

Gradual, controlled treatment of low or high sodium levels may reduce the risk of nerve damage in the pons. Being aware of how some medications can change sodium levels can prevent these levels from changing too quickly.

Update Date: 9/10/2006

Updated by: Daniel Kantor, M.D., Director of the Comprehensive MS Center, Neuroscience Institute, University of Florida Health Science Center, Jacksonville, FL. Review provided by VeriMed Healthcare Network.

A.D.A.M. Logo

The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed physician should be consulted for diagnosis and treatment of any and all medical conditions. Call 911 for all medical emergencies. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. Copyright 1997-2008, A.D.A.M., Inc. Any duplication or distribution of the information contained herein is strictly prohibited.